Dog beside veterinary parasite-prevention reference materials.
Pharmaceuticals2026-05-19 · 8 min read

Trifexis for Dogs: Flea, Heartworm, and Worm Coverage, Safety, and How It Compares

Trifexis (spinosad + milbemycin oxime) for dogs: what it covers, dosing, vomiting risk, seizure precautions, gaps in coverage, and how it compares to Simparica Trio and NexGard Plus.

Ran Chen
Ran Chen
Founder, VetMedGuide. Life-sciences operator and 10× global market-access lead.
Published

Trifexis (spinosad + milbemycin oxime) is a monthly chewable tablet for dogs that prevents heartworm disease, kills fleas, and treats and controls hookworms, roundworms, and whipworms. It has been on the market since 2011 and was at one point the most prescribed combination parasiticide in the United States. It is FDA-approved under NADA 141-321 and manufactured by Elanco.

This article explains what Trifexis covers, how it works, what side effects to expect, what safety questions owners and veterinarians should consider, and where it fits relative to newer combination preventives like Simparica Trio and NexGard Plus.

Quick answer

Trifexis is a once-monthly, beef-flavored chewable tablet labeled for dogs and puppies 8 weeks of age and older weighing at least 5 pounds. It prevents heartworm disease, kills fleas and prevents flea infestations, and treats and controls adult hookworm, roundworm, and whipworm infections. It does not kill ticks and does not cover tapeworms. The most common side effect is vomiting — puppies under 14 weeks may vomit more frequently. It should be used with caution in dogs with a history of seizures or epilepsy.

What Trifexis covers

Parasite What Trifexis does
Heartworm (Dirofilaria immitis) — larvae Prevents development of heartworm disease when given monthly
Fleas (Ctenocephalides felis) — adults Kills fleas; starts killing within 30 minutes; prevents infestations
Hookworm (Ancylostoma caninum) — adults Treatment and control
Roundworm (Toxocara canis, Toxascaris leonina) — adults Treatment and control
Whipworm (Trichuris vulpis) — adults Treatment and control
Ticks Not covered
Tapeworms Not covered
Mange mites Not covered
Ear mites Not covered

Trifexis kills fleas by systemic action — fleas must bite the dog to ingest spinosad. It does not repel fleas. After a dog starts Trifexis, any fleas already on the dog will be killed, and new fleas that jump on will be killed before they can lay eggs. Continued monthly use prevents environmental contamination.

How Trifexis works

Trifexis contains two active ingredients with different mechanisms:

Spinosad is a naturally derived insecticide originally isolated from a soil bacterium (Saccharopolyspora spinosa). It activates nicotinic acetylcholine receptors in the flea nervous system, causing rapid excitation, paralysis, and death. Spinosad circulates in the dog's bloodstream for one month after oral administration.

Milbemycin oxime is a macrocyclic lactone anthelmintic that opens chloride channels in parasite nerve and muscle cells, causing paralysis and death of intestinal worms and heartworm larvae. The milbemycin oxime component is the same antiparasitic used in Interceptor (milbemycin oxime alone) and Sentinel products (milbemycin oxime + lufenuron).

Dosing and administration

Trifexis must be given with food for maximum effectiveness. The label states to give the tablet orally, once a month, at a minimum dosage of 13.5 mg/lb (30 mg/kg) spinosad and 0.2 mg/lb (0.5 mg/kg) milbemycin oxime.

Dog weight Spinosad Milbemycin oxime
5–10 lbs 140 mg 2.3 mg
10.1–20 lbs 270 mg 4.5 mg
20.1–40 lbs 560 mg 9.3 mg
40.1–60 lbs 810 mg 13.5 mg
60.1–120 lbs 1620 mg 27 mg

Dogs over 120 pounds receive a combination of tablets to reach the appropriate dose.

Vomiting protocol

The label instructs owners to observe the dog for one hour after administration. If vomiting occurs within that hour, redose with a full tablet. During clinical field studies, no severe or prolonged vomiting was observed.

Missed doses

Give the missed dose as soon as you remember, and restart the monthly schedule from that date. If multiple months are missed, contact your veterinarian — the dog may need a heartworm test before restarting prevention.

Safety and side effects

Common adverse reactions

From the FDA-approved label and field studies:

  • Vomiting (the most common reaction; higher rate in puppies under 14 weeks)
  • Depression or lethargy
  • Decreased appetite
  • Diarrhea
  • Itching (pruritus)
  • Skin redness or inflammation

Post-marketing reports

Since Trifexis was introduced, additional side effects reported to the manufacturer include:

  • Trembling or shaking
  • Ataxia (loss of coordination)
  • Seizures
  • Hypersalivation

These reactions are uncommon but are listed on the label.

Important safety warnings

Seizure history. The label states: "Use with caution in dogs with pre-existing epilepsy." If your dog has a history of seizures, discuss this with your veterinarian before starting Trifexis. Alternative preventives that do not carry a seizure precaution may be more appropriate.

Ivermectin interaction. Serious adverse reactions — including tremors, seizures, ataxia, blindness, and disorientation — have been reported following concomitant extra-label use of ivermectin with spinosad. Spinosad is a P-glycoprotein substrate and inhibitor; it can increase the blood levels of other P-gp substrates. At label doses, ivermectin-containing heartworm preventives are considered safe when used concurrently with Trifexis. The risk applies specifically to extra-label (higher-than-labeled) ivermectin doses.

Allergen content. The tablet contains artificial beef flavoring derived from pork-based proteins and hydrolyzed soy. Dogs with confirmed pork or soy allergies should not receive Trifexis.

Breeding animals. Use with caution in breeding females. The safe use in breeding males has not been evaluated.

Heartworm testing. Dogs must test heartworm-negative before starting Trifexis. Giving a heartworm preventive to a dog that already has adult heartworms can cause a reaction as circulating microfilariae die.

MDR1 gene mutation

The milbemycin oxime dose in Trifexis is within the range determined safe for dogs with the MDR1 (ABCB1) gene mutation, including Collies, Australian Shepherds, and other susceptible breeds. Sensitivity concerns for macrocyclic lactones apply primarily to doses well above the prevention level.

What Trifexis does not cover

This is where many owner questions arise, especially when comparing Trifexis to newer products:

  • No tick coverage. Trifexis does not kill or repel ticks. If your dog needs tick protection — which the CAPC recommends year-round in most of the United States — you will need a separate tick preventive.
  • No tapeworm coverage. Trifexis does not treat tapeworms. Dogs that hunt, have flea exposure, or live in areas with high tapeworm prevalence may need a separate dewormer containing praziquantel.
  • No coverage for mange, ear mites, or demodex. Products containing selamectin (Revolution) or moxidectin may address these parasites.

How Trifexis compares to other combination preventives

Feature Trifexis Simparica Trio NexGard Plus Sentinel Spectrum
Heartworm prevention Yes Yes Yes Yes
Flea kill Yes Yes Yes No (sterilizes only)
Tick kill No Yes Yes No
Hookworm Yes Yes Yes Yes
Roundworm Yes Yes Yes Yes
Whipworm Yes No Yes Yes
Tapeworm No Prevents flea tapeworm (since April 2025) No Yes
Minimum age 8 weeks 8 weeks 8 weeks 6 weeks
Minimum weight 5 lbs 2.8 lbs 4 lbs 2 lbs
Route Oral chewable Oral chewable Oral chewable Oral chewable
Active ingredients Spinosad + milbemycin oxime Sarolaner + moxidectin + pyrantel Afoxolaner + moxidectin + pyrantel Milbemycin oxime + lufenuron + praziquantel
Seizure caution on label Yes Yes (isoxazoline class) Yes (isoxazoline class) No

When Trifexis may be the right fit

  • Dogs that need flea and heartworm coverage in one chewable but do not need tick protection.
  • Owners who prefer a non-isoxazoline flea killer (spinosad is not an isoxazoline and does not carry the FDA's isoxazoline class warning about neurologic adverse events, though Trifexis has its own seizure precaution).
  • Dogs that have tolerated Trifexis well in the past and have no history of seizures.

When a different product may be better

  • Dogs that need tick coverage should use Simparica Trio, NexGard Plus, or a separate tick preventive alongside Trifexis.
  • Dogs with a history of seizures or epilepsy should avoid Trifexis per label guidance; options like Sentinel Spectrum (which does not carry a seizure precaution) may be worth discussing.
  • Dogs that need tapeworm coverage should use Sentinel Spectrum, Simparica Trio (which prevents flea tapeworm infections as of an April 2025 FDA label update), or a praziquantel-containing product.
  • Very small dogs under 5 pounds cannot use Trifexis; Simparica Trio goes down to 2.8 lbs and Sentinel Spectrum to 2 lbs.

Questions to ask your veterinarian

  • Does my dog need tick protection in addition to flea and heartworm prevention?
  • Has my dog been tested for heartworm disease before starting prevention?
  • Does my dog have a history of seizures or neurologic conditions?
  • Does my dog have known pork or soy allergies?
  • How does the cost of Trifexis compare to Simparica Trio or NexGard Plus for my dog's weight?

Sources